Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Forns

Showing results (181-190 of 298) with videos related to

Pageof 30
Sort By:
Frontiers in Immunology|March 13, 2020
Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free TherapyElena Perpiñán, Sofía Pérez-Del-Pulgar, María-Carlota Londoño, et al.
Journal of Hepatology|October 5, 2014
The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosisMaria-Carlota Londoño, Christie Perelló, Joaquín Cabezas, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 21, 2015
HEV infection in two referral centers in Spain: epidemiology and clinical outcomesSabela Lens, Laura Mensa, Martina Gambato, et al.
Virus Research|July 29, 2017
Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replicationMairene Coto-Llerena, George Koutsoudakis, Loreto Boix, et al.
Brain, Behavior, and Immunity|March 16, 2019
Association of chronic inflammation and perceived stress with abnormal functional connectivity in brain areas involved with interoception in hepatitis C patientsGiovanni Oriolo, Laura Blanco-Hinojo, Ricard Navines, et al.
Gastroenterology|November 2, 2010
Telaprevir is effective given every 8 or 12 hours with ribavirin and peginterferon alfa-2a or -2b to patients with chronic hepatitis CPatrick Marcellin, Xavier Forns, Tobias Goeser, et al.
The Journal of Rheumatology|August 2, 2006
Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndromeManuel Ramos-Casals, Jose-María Sánchez-Tapias, Albert Parés, et al.
Gastroenterologia Y Hepatologia|October 2, 2018
Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)Jose L Calleja, Juan Macias, Xavier Forns, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 12, 2023
Low risk of viral hepatitis amongst patients with severe mental disordersTábatha Fernández, Teresa Plana, Laia Tardón, et al.
Gastroenterology|July 5, 2016
Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free RegimenMartina Gambato, Sofía Pérez-Del-Pulgar, Charlotte Hedskog, et al.
Pageof 30

Showing results (181-190 of 298) with videos related to

Sort By:
Pageof 30
Frontiers in Immunology|March 13, 2020
Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free TherapyElena Perpiñán, Sofía Pérez-Del-Pulgar, María-Carlota Londoño, et al.
Journal of Hepatology|October 5, 2014
The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosisMaria-Carlota Londoño, Christie Perelló, Joaquín Cabezas, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 21, 2015
HEV infection in two referral centers in Spain: epidemiology and clinical outcomesSabela Lens, Laura Mensa, Martina Gambato, et al.
Virus Research|July 29, 2017
Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replicationMairene Coto-Llerena, George Koutsoudakis, Loreto Boix, et al.
Brain, Behavior, and Immunity|March 16, 2019
Association of chronic inflammation and perceived stress with abnormal functional connectivity in brain areas involved with interoception in hepatitis C patientsGiovanni Oriolo, Laura Blanco-Hinojo, Ricard Navines, et al.
Gastroenterology|November 2, 2010
Telaprevir is effective given every 8 or 12 hours with ribavirin and peginterferon alfa-2a or -2b to patients with chronic hepatitis CPatrick Marcellin, Xavier Forns, Tobias Goeser, et al.
The Journal of Rheumatology|August 2, 2006
Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndromeManuel Ramos-Casals, Jose-María Sánchez-Tapias, Albert Parés, et al.
Gastroenterologia Y Hepatologia|October 2, 2018
Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)Jose L Calleja, Juan Macias, Xavier Forns, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 12, 2023
Low risk of viral hepatitis amongst patients with severe mental disordersTábatha Fernández, Teresa Plana, Laia Tardón, et al.
Gastroenterology|July 5, 2016
Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free RegimenMartina Gambato, Sofía Pérez-Del-Pulgar, Charlotte Hedskog, et al.
Pageof 30